Interparfums Shares Climb 4% and Challenge the €27.70 Resistance
The licensed perfumery specialist continues its rebound that began in late May. The stock continues its recovery in a decidedly bullish Parisian market, while approaching a technical threshold monitored for several sessions.
Interparfums shares gained 4.1% to €27.44 during the session, in an SBF 120 that rose by 2.21%. The stock is now testing its resistance at €27.70, a long-identified threshold; crossing it would pave the way for new highs. Today's progress brings the gain to 21.63% over a month, a pace that erases a large part of the decline accumulated since the summer of 2025.
The RSI climbs to 71, in the overbought zone, which reflects the intensity of the bullish movement in recent weeks rather than a temporary drift. The price is now above its three moving averages, with a gap of 13.5% over the MM20 and 6.9% over the MM200, indicating a trend reversal after the multi-year low of €21.78 touched in mid-May.
A Rebound Supported by a More Favorable Climate for Luxury and Cosmetics
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The movement is part of a session largely oriented towards growth on the Parisian stock exchange, where Kering also jumped by more than 6%. The sectoral environment provides support: retail sales of cosmetics in China grew by 4.7% year-on-year in April 2026, while global retail stagnated at +0.2%, a relevant dynamic for a group exposed to the Chinese market through its licenses. During the annual results announcement for 2025 (January 22, 2026), the company targeted an operating margin between 19% and 19.5%, and planned about fifteen line extensions in 2026, with an improvement in results expected from 2027.
Over a year, the stock is still down by 21.1%, which highlights the extent of the recovery since the low point in May. The €27.70 resistance remains the key level to watch to confirm the continuation of the rebound.
We had a very good year in 2025 after all, in line with our initial budget forecasts, thanks in particular to the commitment and work of all of our teams.
2025 résultats positifs avec une croissance portée par plusieurs marques; incertitudes économiques et géopolitiques limitant la visibilité pour 2026; avenir prometteur avec des lancements et acquisitions prévus.
Risks mentioned
incertitudes économiques, géopolitiques et monétaires
visibilité faible pour 2026
impact éventuel du change euro/dollar
disruptions dans certains marchés (Corée et Inde)
Opportunities identified
Lancements prévus en 2026 (~15 extensions de lignes)
Nouvelles franchises et acquisitions (Annick Goutal, Off-White, Longchamp)
Amélioration potentielle des résultats à partir de 2027
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.